Founder & Chair @PPHSUMMIT. Chairman & CEO @QuanterixSimoa. #PrecisionHealth Pioneer, #Biotech Entrepreneur, Author, Healthspan Visionary Transforming Medicine
Boston, MA
Joined January 2010
- Tweets2.2K
- Following3.1K
- Followers2K
- Likes561
Thrilled to announce that @QuanterixSimoa is partnering with and received funding from @TheADDF to accelerate the development of a #multianalyte plasma test for #Alzheimers. Learn more about the advancements we hope to spearhead with ADDF & @AmsterdamUMC: bwnews.pr/3LqZlmg
A new @ScienceMagazine study has revealed the critical role NfL plays in #MS research! Thanks to @QuanterixSimoa’s ability to measure NfL at ultra-low levels, researchers found that Epstein-Barr virus greatly increased the risk of subsequent MS: bit.ly/33QG4dx
#ICYMI: At #JPM22 yesterday, we discussed how Quanterix is disrupting #proteomics, particularly in #neuro and #Alzheimers research. Excited to see the breakthroughs discovered and advances in diagnostics made through the support of #Simoa and @PPHSUMMIT! bit.ly/3fnpQv9
As always, great conversation with @bloombergbaybiz this week on @QuanterixSimoa’ 2021 milestones! Thanks for the opportunity, @AnneMostue.
This Post is from an account that no longer exists. Learn more
Had a great time presenting on @QuanterixSimoa’s 2021 achievements at the @jpmorgan Healthcare Conference this morning! Exciting developments ahead: bwnews.pr/3rdC6nd #JPM22
Through @QuanterixSimoa and @PPHSUMMIT, the goal is to revolutionize the way #healthcare is provided, from reactive sick care to truly preventative healthcare. Had a great opportunity to share this vision with @BostonGlobe: bit.ly/3Fh1xtR #precisionhealth
Congratulations to David Walt on being awarded the prestigious @NorthwesternU Kabiller Prize! David is a #precisionhealth pioneer whose contributions to modern medicine – including Simoa – have revolutionized how we detect and treat #cancer and disease! bit.ly/3wfoIRV
A new #cancer drug gets #FDA ✅: Patients with early-stage HR+ and HER2- early #breastcancer could have a new standard of care, with #Verzenio now approved. An incredible advancement that will help countless patients in their fight. wb.md/3nhFOdQ
Congratulations, @luba_greenwood. This is terrific news and huge for women in #biotech – a woman CEO with an all-woman C-suite!
This quoted post is unavailable.
The @US_FDA's Breakthrough Device designation for the Simoa pTau-181 #bloodtest marks yet another important milestone in our Powering #PrecisionHealth journey. As an aid in diagnosing #Alzheimers, we're closer to our goal of using #biomarkers to #EndAlz! bit.ly/30tb01R
Kevin Hrusovsky retweeted
Join @KevinHrusovsky on September 16th as he discusses how Emory University implemented COVID-19 testing for their students, faculty, and staff with Dr. John D. Roback, Professor in the Department of Pathology and Laboratory Medicine. Register: bit.ly/3E4YdC0
I’ll be chatting with @NicholasAshton on his work with some special biomarkers!
There is still time to register for the Biomarkers for #Alzheimer’s Disease Summit happening August 24-26! We are proud to sponsor this event with a virtual booth and a presentation on recent advances in blood-based #biomarkers for AD. More info: bit.ly/3kcCqPN
Kevin Hrusovsky retweeted
Interesting food for thought for those of us in #healthcare. MLB veteran Theo Epstein at #HIMSS21 drew a parallel between baseball and analytics, teamwork and culture. Awesome read! bit.ly/3jITw7x
Love this countdown and this research! What was your favorite abstract or preso from #AAIC21 ?
Simoa technology continues to facilitate key #ALZ disease research, as evidenced by more than 80 abstracts based on Simoa technology presented at #AAIC2021. Check out our picks for the top 5 abstracts from AAIC 2021. youtu.be/8jcDNVxRssM
Outstanding work shown at #AACI21. The Quanterix team will remain focused on bringing key #biomarkers to these researchers as we pioneer a new field of ‘neuro diagnostic therapies’ to improve outcomes for those suffering from diseases like #Alzheimers! bit.ly/2VDD9AE
Kevin Hrusovsky retweeted
Excited to announce the appointment of six new individuals to our Scientific Advisory Board! Please join us in welcoming Ileana Cristea, @1jvaneyk, Anne-Claude Gingras, Jesper Olsen, @RenASRobinson1, and @JohnRYatesIII. Read more details here: 908devices.com/news/908-devi…
Kevin Hrusovsky retweeted
Please join me now on @ms_cme for my accredited tweetorial launching TODAY on MRI and #biomarkers in the diagnosis of #multiplesclerosis. Free CE/#CME!! Follow us, @SFHunterMDPhD @DrJNicholas @AaronBosterMD @Brandon_Beaber @EmilyPharrMD @dr_niall @StaceyLClardy
Great to see Simoa blood based biomarkers tracking with amyloid PET and the significant impact on plaque reduction of Donanemab! #AAIC21
